In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors

Xuexiang Han,Junchao Xu,Ying Xu,Mohamad-Gabriel Alameh,Lulu Xue,Ningqiang Gong,Rakan El-Mayta,Rohan Palanki,Claude C. Warzecha,Gan Zhao,Andrew E. Vaughan,James M. Wilson,Drew Weissman,Michael J. Mitchell
DOI: https://doi.org/10.1038/s41467-024-45537-z
IF: 16.6
2024-02-26
Nature Communications
Abstract:Abstract The ionizable lipidoid is a key component of lipid nanoparticles (LNPs). Degradable lipidoids containing extended alkyl branches have received tremendous attention, yet their optimization and investigation are underappreciated. Here, we devise an in situ construction method for the combinatorial synthesis of degradable branched (DB) lipidoids. We find that appending branch tails to inefficacious lipidoids via degradable linkers boosts mRNA delivery efficiency up to three orders of magnitude. Combinatorial screening and systematic investigation of two libraries of DB-lipidoids reveal important structural criteria that govern their in vivo potency. The lead DB-LNP demonstrates robust delivery of mRNA therapeutics and gene editors into the liver. In a diet-induced obese mouse model, we show that repeated administration of DB-LNP encapsulating mRNA encoding human fibroblast growth factor 21 alleviates obesity and fatty liver. Together, we offer a construction strategy for high-throughput and cost-efficient synthesis of DB-lipidoids. This study provides insights into branched lipidoids for efficient mRNA delivery.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to efficiently construct degradable branched lipidoids (DB - lipidoids) through combinatorial synthesis methods to improve the systemic delivery efficiency of mRNA therapeutics and gene editors. Specifically, the researchers developed an in - situ combinatorial synthesis strategy for the rapid and high - throughput synthesis of DB - lipidoids with specific structural features. These structural features include the total number of carbons, symmetry, and the type of head group, which are crucial for improving the in - vivo delivery efficiency of mRNA. ### Main Problems and Solutions 1. **Synthesis Challenges**: - **Problem**: Traditional synthesis methods are cumbersome and costly, making it difficult to achieve large - scale and systematic optimization. - **Solution**: Developed an in - situ combinatorial synthesis strategy based on one - pot, two - step, three - component reaction (3 - CR), which can rapidly and efficiently synthesize a variety of DB - lipidoids. 2. **Structural Optimization**: - **Problem**: It is necessary to systematically optimize the structure of DB - lipidoids to find the best mRNA delivery effect. - **Solution**: By constructing two combinatorial libraries (Library 1 and Library 2), the structures of the tail region and the head group were optimized respectively. The study found that DB - lipidoids with a total carbon number of 18 and a symmetry of 1 showed the best mRNA delivery effect. 3. **In - Vivo Delivery Effect**: - **Problem**: How to verify and predict the in - vivo mRNA delivery effect of DB - lipidoids. - **Solution**: The in - vivo mRNA delivery effect of the optimized DB - lipidoids in the liver was verified through in - vivo experiments, and the "18 - Carbon Rule" and symmetry rules were proposed to predict the performance of unrecognized DB - lipidoids. ### Experimental Results - **Synthesis Efficiency**: The developed synthesis method is simple and efficient, with an overall yield exceeding 80%, and can be directly used for the preparation and screening of LNPs. - **Structural Optimization**: Through systematic optimization, it was found that DB - lipidoids with a total carbon number of 18 and a symmetry of 1 have the best mRNA delivery effect. - **In - Vivo Effect**: The optimized DB - lipidoids showed a significant mRNA delivery effect in the mouse model, especially in the treatment of obesity and fatty liver, and their effect was better than that of the benchmark DLin - MC3 - DMA (MC3) LNP. ### Conclusion This study provides an efficient synthesis method and structural optimization strategy for constructing high - performance DB - lipidoids, which is of great significance for the delivery of mRNA therapeutics and gene editors. Through these optimizations, the in - vivo mRNA delivery effect of DB - lipidoids has been significantly improved, providing new ideas and tools for future drug development.